Allspring Global Investments Holdings, LLC Precision Biosciences Inc Transaction History

Allspring Global Investments Holdings, LLC

$62.1 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	BUY	$1.22 - $40.8 $6,913 - $231,213	5,667 Added 43.76%	18,618 $24,000
Q2 2022 Jul 25, 2022	SELL	$1.15 - $3.34 $80,008 - $232,373	-69,573 Reduced 84.31%	12,951 $20,000
Q1 2022 May 02, 2022	BUY	$2.96 - $7.76 $32,116 - $84,196	10,850 Added 15.14%	82,524 $254,000
Q4 2021 Jan 28, 2022	BUY	$7.4 - $11.66 $530,387 - $835,718	71,674 New	71,674 $530,000

Others Institutions Holding DTIL

# of Institutions

Shares Held

2.56M

Call Options Held

Put Options Held

Oup Management Co., LLC

1.12M
Shares

$5.62 Million
0.86% of portfolio
Chi Advisors LLC New York, NY

607K
Shares

$3.03 Million
0.1% of portfolio
Jacob Asset Management Of New York LLC Hermosa Beach, CA

390K
Shares

$1.95 Million
0.19% of portfolio
Tekla Capital Management LLC

225K
Shares

$1.12 Million
0.0% of portfolio
Vericrest Private Wealth Newtown, PA

155K
Shares

$773,470
0.3% of portfolio

View Full List

About PRECISION BIOSCIENCES INC

Ticker DTIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 110,818,000
Market Cap $554M
Description
Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing and ex vivo allogeneic CAR T therapies in the United States. It offers ARCUS, a genome editing platform to cure genetic disorders. The company also provides Ex vivo Allogeneic CAR T Immunotherapy, a form of immunotherapy in which T cell, a specific ...

More about DTIL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.

Account